STOCKS TELEGRAPH

Tag: TYME

  • Why Tyme Technologies, Inc. (TYME) stock is moving high today?

    Tyme Technologies, Inc. (TYME) stock announced the receival of notification from the United States Patent and Trademark Office that states the grant of additional patent claims regarding Tyme’s metabolomic technology platform. The TYME stock price saw a push of 38.89% to reach $1.50 a share as of this writing. The stock was gloomy at the previous trading session and went down by 2.70%. Let’s deep dive to explore more of it.

    What’s Happening?

    Tyme Technologies, Inc is the biotechnology stock focused on the development of therapeutics related to cancer metabolism in the United States of America. The U.S patent no 11,058,638 which the TYME stock has been granted is related to the delivery of therapeutics to the targeted cancer cells.

    TYME stock Technology:

    The technology of the Tyme Technologies works in such a manner that the tyrosine isomer racemetyrosine fuses a second therapeutic agent in order to create a fusion compound that allows the targeted delivery to cancer cells in a novel manner. This delivery method affirms the metabolic phenomenon in which the cancer cells grow by consuming a high quantity of non-essential amino acids, in which tyrosine is also included. These cancer cells get non-essential amino acids from their surrounding as they themselves cannot make enough of these i.e., amino acids.

    This delivery technology requires further studies which TYME stock is planning to start this year. As it is the investigational procedure of drug delivery in the pre-clinical phase, it is not approved by the U.S for any disease indication.

    TYME stock’s Chief Scientific Officer Remarks:

    The Chief Scientific Officer of the TYME stock considered the delivery technology as the opportunity for Tyme Technologies for the expansion of TYME’s current cancer-metabolism-based approach with a drug delivery platform. He emphasized that this technology would help in the improvement of safety and efficacy of the wide range of anticancer drugs.

    Conclusion:

    Investors are responding to the recent news related to the U.S patent which TYME stock did announce today. The stock is bullish today and the trading volume is well above the average. The delivery technology of TYME is in the early stages but it can leverage itself in the future.

  • Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

    On February 9, American stock exchanges were trading in narrow ranges. The S&P 500 index fell 0.11% to 3911 points, the Dow Jones lost a symbolic 0.03%, the NASDAQ added 0.14%. The upward movement has stalled due to the lack of new drivers. The energy sector corrected 1.52% after the rally the day before. The strongest was the real estate sector, which added 0.47%.

    Company news

    Game developer Take-Two Interactive Software (TTWO: -6.1%) beat expectations, but stock corrected due to lack of clarity on its fiscal 2022 release schedule.

    Shopify e-commerce platform (SHOP: + 6.5%) announced the integration of the Shop Pay payment method on Facebook and Instagram.

    Electronic Arts (EA: + 2.6%) buys mobile game developer Glu Mobile (GLUU: + 35%) for cash. The deal will amount to $ 2.1 billion.

    Today, world stock exchanges are showing mostly positive dynamics. The news background is calm. The Biden administration said on Monday that the fiscal stimulus package will likely be passed through a simplified voting procedure requiring only a Democratic majority for approval. However, this was already a highly anticipated scenario, since President Biden, the majority of Democrats, and Treasury Secretary Janet Yellen insist on a significant amount of the anti-crisis program. This positive factor continues to support buyers, but to a large extent it has already been taken into account in the quotes. The only question that remains is what changes the bill will undergo in order to be approved by the centrist democrats.

    The Freedom Finance Sentiment Index climbed to 57 out of 100. The index reflects market participants’ hope for a global economic recovery in 2021. Concerns about the negative impact of the coronavirus pandemic are gradually diminishing with the approach of mass vaccinations.

    Technical picture

    Technically, the S&P 500 is still in a medium-term uptrend. The trading session the day before did not change the overall picture. The upper limit of the trend at 3920 is still a significant obstacle. After the S&P 500 rallied 4% last week, short-term consolidation is likely.

    Today Top Movers

    Sundial Growers Inc (SNDL), a drug manufacturer company, soared about 18.18% ‎at $1.95 in pre-market ‎trading Wednesday.‎‎ 

    ‎Tilray Inc (TLRY) share price jumped 24.53% to $52.74 during the early morning ‎trading session on ‎Wednesday after declaring an agreement with British company Grow Pharma, to export medical marijuana to the U.K. ‎‎ 

    ‎Gamida Cell Ltd (GMDA) stock ascended 55.01% at $15.33 in the pre-‎market trading today.‎‎ The company recently revealed the results of Phase 3 clinical study of omidubicel. 

    ‎Genfit (GNFT) gained over 29.30% at $6.84 in pre-market ‎trading on Wednesday following the publication of positive results from the phase 2 clinical trial evaluating elafibranor in patients with PBC in the Journal of Hepatology.‎

    Top Upgrades & Downgrades

    SVB Leerink turned bullish on Deciphera Pharmaceuticals Inc. (DCPH), upgrading the stock to “Outperform” and assigning a $70.0 price target, representing a potential upside of 44.87% from Tuesday’s close.

    Model N Inc. (MODN) has won the favor of JP Morgan’s equity research team. The firm upgraded the shares from Underweight to Neutral and moved their price target to $40.

    The Hain Celestial Group Inc. (HAIN) received an upgrade from analysts at Piper Sandler, who also set their one-year price target on the stock to $50.0. They changed their rating on HAIN to Overweight from Neutral in a recently issued research note.

    Earlier Wednesday Raymond James reduced its rating on Leggett & Platt Incorporated (LEG) stock to Outperform from Strong Buy.

    JPMorgan analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Change Healthcare Inc. (CHNG) has been changed to Neutral from Overweight and the new price target is set at $25.75.

    Analysts at Mizuho downgraded Corvus Pharmaceuticals Inc. (CRVS)’s stock to Neutral from Buy Wednesday.

    Latest Insider Activity

    Tyme Technologies Inc. (TYME) 10% Owner Demurjian Michael announced the sale of shares taking place on Feb 08 at $2.45 for some 20,000 shares. The total came to more than $49000.

    Square Inc. (SQ) Chief Financial Officer Ahuja Amrita sold on Feb 05 a total of 149,866 shares at $240.45 on average. The insider’s sale generated proceeds of almost $1.01 million.

    International Business Machines Corporation (IBM) Director HOWARD MICHELLE J declared the purchase of shares taking place on Feb 08 at $123.30 for some 64 shares. The transaction amount was around $7891.

    UnitedHealth Group Incorporated (UNH) Director FLYNN TIMOTHY PATRICK bought on Feb 05 a total of 6,972 shares at $332.68 on average. The purchase cost the insider an estimated $499,026.

    Important Earnings


    Top US earnings releases scheduled for today include Veru Inc. (NASDAQ: VERU). It will announce its Dec 2020 financial results. The company is expected to report earnings of -$0.06 per share from revenues of $10.57M in the three-month period.

    Analysts expect General Motors Company (NYSE: GM) to report a net income (adjusted) of $1.64 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $36.12B.

    Uber Technologies Inc. (UBER), due to announce earnings after the market closes today, is expected to report earnings of -$0.55 per share from revenues of $3.58B recently concluded three-month period.

  • Early Morning Vibes: Watch These 4 Stocks Today

    The US stock indexes were traded in small ranges on January 12. The S&P 500 has risen symbolically by 0.04% to 3801 points, with the Dow Jones and the NASDAQ contributing 0.19% and 0.28%, respectively. New drivers have been absent. The Russel 2000 small-cap index nevertheless increased by 1.77 percent, which indicates an increased propensity for risk. The energy industry was the pioneer in growth and has benefited 3.5% from the upward oil dynamics. The telecom market has sunk by 1.5 percent under pressure.

    Corporate Updates

    Walmart (WMT: + 1.15%) announced plans to create a fintech startup in partnership with venture capital fund Ribbit Capital, which backs broker Robinhood.

    Intel (INTC: + 3.3%) will increase production of new server processors. The company also unveiled 12th generation Alder Lake processors.

    Sports streaming service fuboTV (FUBO: + 34.2%) takes over the Vigtory bookmaker to launch its own bookmaker service by the end of the year.

    Today, foreign financial markets show mixed trends. The background of the news is quiet. Current activities in the United States linked to Donald Trump’s potential arrest had little impact on the movement of quotes as they does not conflict with the vaccine programme. The administration of Trump has meanwhile revealed reforms to promote the vaccine process. The key point of these improvements was that the second dose vaccine was spread rather than stored for two weeks. The list of people who will get the coronavirus vaccine has risen and there will be a substantial rise in the number of vaccination stations. The financial group is currently less concerned with morbidity and hospitalization rates. On 6 January the last maximum number of people injured was 132,5 thousand.

    Investors took a wait-and-see stance before big developments on Thursday and Friday. Note that on 14 January Joseph Biden will deliver a package of economic support initiatives and the season of quarterly bank reports will commence on 15 January. Consolidation is most likely in this regard during the current session.

    Economic news

    The December Core CPI will be published today. In November, the growth of the indicator is forecast to decline from 0.2% to 0.1% m/m. Despite substantial monetary and fiscal stimuli, inflationary pressures are expected to stay subdued in the short term. The second half of this year is expected to see a steady acceleration of inflation. The Sentiment Index of Freedom Finance plummeted to 58 out of 100. The measure represents the belief of industry players that the global economy will rebound in 2021. The possibility of mass vaccines alleviates fears over the harmful consequences of the coronavirus pandemic.

    Technical picture

    The S&P 500 is technically vulnerable to short-term consolidation. The day before, there was no effort to establish a correctional movement: buyers were solid. However, the RSI indicator remains close to the overbought zone, which still limits the growth prospects. Besides, in the area of ​​3825-3830 points, there is strong resistance in the form of the upper border of the equidistant channel. If a corrective movement develops, the first significant target for the S & P500 will be the level of 3700 points.

    Today Top Movers

    ‎Aprea Therapeutics Inc (APRE) gained over 18.13% at $6.06 in pre-market ‎trading on Wednesday after the company provided financial updates.

    ‎ ‎‎Plug Power Inc (PLUG) share price jumped 3.53% to $68.35 during the early morning ‎trading session on Wednesday after declaring a partnership with Renault, a French automaker, to become a leader in Hydrogen LCV.‎ ‎

    ‎Tonix Pharmaceuticals Holding Corp (TNXP), a biotechnology company, soared ‎about 30.81% ‎at $1.21 in pre-market trading Wednesday following the pricing $40M common stock offering.‎‎‎ ‎‎

    ‎Fluent Inc (FLNT) stock ascended 12.15% at $6.00 in the pre-‎market trading today.‎

    Top Upgrades & Downgrades

    JP Morgan turned bullish on Exxon Mobil Corporation (XOM), upgrading the stock to “Overweight” and assigning a $56.0 price target, representing a potential upside of 16.97% from Tuesday’s close. 

    Sabra Health Care REIT Inc. (SBRA) has won the favor of Jefferies’s equity research team. The firm upgraded the shares from Hold to Buy and moved their price target to $20.0, suggesting 17.03% additional upside for the stock. 

    Omega Healthcare Investors Inc. (OHI) received an upgrade from analysts at Jefferies, who also set their one-year price target on the stock to $40.0. They changed their rating on OHI to Buy from Hold in a recently issued research note. 

    Earlier Wednesday KeyBanc reduced its rating on Take-Two Interactive Software Inc. (TTWO) stock to Sector Weight from Overweight. 

    Piper Sandler analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for The PNC Financial Services Group Inc. (PNC) has been changed to Neutral from Overweight and the new price target is set at $167. 

    Analysts at HSBC downgraded DuPont de Nemours Inc. (DD)’s stock to Hold from Buy Wednesday.

    Latest Insider Activity

    Tyme Technologies Inc. (TYME) 10% Owner Demurjian Michael announced the sale of shares taking place on Jan 11 at $1.62 for some 20,000 shares. The total came to more than $32426.

    Hecla Mining Company (HL) Director Rogers Terry V sold on Jan 08 a total 48,103 shares at $6.25 on average. The insider’s sale generated proceeds of almost $0.28 million.

    Foot Locker Inc. (FL) 10% Owner Vesa Equity Investment S.a r.l declared the purchase of shares taking place on Jan 04 at $39.00 for some 8,581 shares. The transaction amount was around $0.33 million.

    DermTech Inc. (DMTK) 10% Owner RTW INVESTMENTS, LP bought on Jan 07 a total 3,087,216 shares at $29.50 on average. The purchase cost the insider an estimated $5.9 million.

    Important Earnings

    Top US earnings releases scheduled for today include Infosys Limited (NYSE: INFY). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.15 per share from revenues of $3.38B in the three-month period.

    Analysts expect Washington Federal Inc. (NASDAQ:WAFD) to report a net income (adjusted) of $0.42 per share, when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $115.53M.

    Volt Information Sciences Inc. (VOLT), due to announce earnings after the market closes today, is expected to report earnings of $0.01 per share from revenues of $205.5M recently concluded three-month period.